Activating mutations in BRAF are found in 3% of non small-cell lung cancers [1], [2], [3], and mouse models have shown that expressing the mutant form of BRAF (BRAFV600E) in lung epithelium induce the formation of benign lung tumors [7], [8]. Here, BRAF is linked to non-small cell lung carcinoma.